Gilles Berclaz

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 565 citations

Medicine, Oncology, Surgery +17

Morbidity of Sentinel Lymph Node Biopsy (SLN) Alone Versus SLN and Completion Axillary Lymph Node Dissection After Breast Cancer Surgery

Igor Langer, Ulrich Güller, Gilles Berclaz et al. · Annals of Surgery · 2007 · 358 citations · Full text

Medicine, Oncology, Surgery +17

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience

Gilles Berclaz, S. Li, Karen N. Price et al. · Annals of Oncology · 2004 · 260 citations · Full text

Medicine, Oncology, Surgery +9

The Central-European SentiMag study: Sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope

Marc Thill, Andrzej Kurylcio, Rebekka Welter et al. · The Breast · 2014 · 197 citations · Full text

Medicine, Nuclear Medicine, Oncology +15

Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?

Günther Gruber, Richard Greiner, Ruslan Hlushchuk et al. · Breast Cancer Research · 2004 · 134 citations · Full text

Medicine, Cancer Biology, Oncology +16